PO.BCS02.04 · 生物信息与计算

利用癌症规模基础模型从全切片图像中学习空间转录组模式

Learning spatial transcriptomic patterns from whole-slide images with a cancer-scale foundation model

海报缩略图:利用癌症规模基础模型从全切片图像中学习空间转录组模式
编号 2778 展板 9 时间 4/20 02:00–05:00 区域 Section 4 主讲 Minsoo Lee
分会场 Radiomics and AI in Medical Imaging
查看 PDF 下载 PDF 🔒 查看 / 下载完整 PDF 需登录并开通下载套餐 · 查看套餐 / 开通 AACR 官方页面

作者与单位 Authors & Affiliations

Minsoo Lee1, Soonyoung Lee1, Tae Hyun Hwang2, Jongseong Jang1

1LG AI Research, Seoul, Korea, Republic of,2Department of Surgery, Vanderbilt University Medical Center, Nashville, TN

摘要 Abstract

中文摘要
背景 空间转录组学(ST)为肿瘤微环境(TME)组织提供了重要见解,但仍然成本高昂且临床可扩展性有限。直接从常规全切片图像(WSI)预测空间基因表达可实现跨多种癌症类型的大规模分子表型分析。然而,现有方法依赖于自监督的图像块编码器和小型基因面板,限制了生物学保真度和跨癌症泛化能力。 方法 为了明确捕捉组织形态学背后的分子变异,我们将基于DINOv2的图像块编码器与空间转录组学预测头联合训练。这种设计使视觉表征与基因表达信号对齐,解决了肿瘤病理中常遇到的形态学模糊性——即外观相似的细胞可能表现出与肿瘤进展或免疫活性相关的不同转录组状态。为了对组织水平的生物学组织进行建模,我们引入了一个整合相邻图像块信息的掩码transformer。空间关系在癌症组织中至关重要,其中基因表达模式由肿瘤-基质界面、免疫龛以及浸润前沿的梯度所塑造。通过参考局部空间背景,该模型捕捉了传统图像块级编码器所忽略的这些微环境依赖关系。 结果 我们在HEST基准上评估了我们的框架,该基准包含十种癌症类型,旨在评估从WSI进行ST预测。在不使用该基准训练数据的情况下,我们的基础模型已经达到了与HEST基准中针对每种癌症类型单独训练的最先进方法相当的性能,展示了强大的跨癌症泛化能力。当在基准内每个癌症队列上进一步微调时,我们的模型大幅超越了先前的方法。定性来看,预测的空间表达图重现了具有临床和生物学意义的组织特征,包括局部表达变化和肿瘤相关区域。这些模式与真实ST图谱高度匹配,表明该模型捕捉了由组织组织所塑造的空间域。 结论 我们的模型表明,大规模预训练能够直接从常规组织学可靠地预测空间基因表达。通过从标准病理切片生成空间基因表达图,该方法可以支持生物标志物评估,增强对肿瘤微环境的表征,并在空间转录组检测不可用的情况下提供价值。总体而言,这些发现凸显了基于基础模型的病理学在临床和研究环境中使空间转录组学见解更易获得的潜力。
查看英文原文 English abstract
Background Spatial transcriptomics (ST) provides essential insights into tumor microenvironment (TME) organization, but remains costly and limited in clinical scalability. Predicting spatial gene expression directly from routine whole-slide images (WSIs) could enable large-scale molecular phenotyping across diverse cancer types. However, existing approaches rely on self-supervised patch encoders and small gene panels, limiting biological fidelity and cross-cancer generalization. Methods To explicitly capture molecular variation underlying tissue morphology, we train a DINOv2-based patch encoder jointly with a spatial transcriptomics prediction head. This design aligns visual representations with gene-expression signals, addressing the morphological ambiguity often encountered in tumor pathology, where cells with similar appearance may exhibit distinct transcriptomic states relevant to tumor progression or immune activity. To model tissue-level biological organization, we introduce a masked transformer that integrates information from neighboring patches. Spatial relationships are crucial in cancer tissues, where gene expression patterns are shaped by tumor-stroma interfaces, immune niches, and gradients across the invasive front. By referencing local spatial context, the model captures these microenvironmental dependencies that conventional patch-level encoders overlook. Results We evaluate our framework on the HEST-benchmark, which comprises ten cancer types designed to assess ST prediction from WSIs. Without using the benchmark's training data, our foundation model already achieves comparable performance to state-of-the-art methods that were trained separately for each cancer type in the HEST-benchmark, demonstrating strong cross-cancer generalization. When further fine-tuned on each cancer cohort within the benchmark, our model surpasses prior approaches by a large margin. Qualitatively, the predicted spatial expression maps reproduce tissue features that are clinically and biologically meaningful, including localized expression changes and tumor-associated regions. These patterns closely match ground-truth ST profiles, indicating that the model captures spatial domains shaped by tissue organization. Conclusion Our model shows that large-scale pretraining enables reliable prediction of spatial gene expression directly from routine histology. By generating spatial gene expression maps from standard pathology slides, this approach can support biomarker assessment, enhance characterization of the tumor microenvironment, and provide value where spatial transcriptomic assays are not available. Overall, these findings highlight the potential of foundation-model-based pathology to make spatial transcriptomic insights more accessible in both clinical and research settings.
利益披露 Disclosure
M. Lee, None.. S. Lee, None.. T. Hwang, None.. J. Jang, None.

← 返回 AACR 2026 检索